You searched for us stem cell - Page 211 of 243

Science press releases behaving badly: time to start tracking their retractions?

January 14, 2016 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 3 Comments

Over at RetractionWatch, their team does a great job following retractions of science papers. Sadly, the number of published manuscript retractions gives them more than enough material to post several times a day. There’s another phenomenon going on that I think might warrant their increased attention: the possibly rising number of retractions or corrections of science …

Science press releases behaving badly: time to start tracking their retractions? Read More »

CRISPR predictions for New Year of 2016

December 27, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 2 Comments

CRISPR is the hottest new biotechnology and the top development of 2015 according to Science Magazine. What will the new year of 2016 bring on the CRISPR front? It’s clear there will be more meetings on CRISPR ethics and policy (heck, we are having one right here at UC Davis on May 26), but what …

CRISPR predictions for New Year of 2016 Read More »

Take a medical selfie: a taste of your own medicine

December 6, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 1 Comment

“Take a Selfie”, has become a catch phrase in pop culture. There is a preoccupation with capturing one’s own existence and key moments in pictures. Another trend is a DIY culture including taking initiative with one’s own health. When combined together we are in the midst of a larger trend in medicine where patients will …

Take a medical selfie: a taste of your own medicine Read More »

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit

December 4, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 7 Comments

I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there …

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit Read More »

Live Blog #GeneEditSummit Day 2 Post #2: International Governance

December 2, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

How do governance issues for human genome editing work at the international level? Indira Nath, All India Institute of Medical Sciences, gives a nice overview to start the session. She raised the example of medical tourism and surrogacy in India. She argued for an international consensus on what is permissible on human gene editing. How …

Live Blog #GeneEditSummit Day 2 Post #2: International Governance Read More »

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing

December 2, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first …

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification

December 1, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 2 Comments

Robin-Lovell-Badge-Peter-Braude-George-Church

The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be …

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR

December 1, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 3 Comments

Human-gene-editing-science-session-small

Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an …

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »

FDA approves 1st GM animal (fast-growing salmon) to eat

November 19, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 14 Comments

After a seemingly endless period of review, the FDA has approved the genetically modified (GM) AquaBounty salmon for sale and consumption. Update: You might find my interview with George Church on CRISPR and gene modification interesting. I don’t see any particular reason to think that this GM fish as a food would pose any significant …

FDA approves 1st GM animal (fast-growing salmon) to eat Read More »

Ocata bought by Astellas of Japan: initial perspectives on end of an era

November 9, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 7 Comments

Bombshell news in the stem cell field as Ocata Therapeutics (OCAT; formerly Advanced Cell Technology or ACT) is reportedly to be acquired by Astellas Pharma, Inc. The offer for purchase of OCAT will be $8.50/share or almost $380 million. For more details see this detailed PDF from Astellas. This quote on the deal form Ocata: “Paul …

Ocata bought by Astellas of Japan: initial perspectives on end of an era Read More »

Search Results for: us stem cell